BIAF Reports $1.4M Revenue, CyPath Lung Sales Up 146% YoY to $361K, Physician Adoption Rises 69%
bioAffinity Technologies, Inc. Common Stock · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $1.75
-16% in 7d after detection
Post-detection moves
1h
—
1d
-3.0%
3d
-6.9%
7d
-16%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS